Stock Ratings / Financials / GRX / financials

GNT (46) SCM (34) FTF (44) ACV (42) ⌘ Pro Terminal →

The Gabelli Healthcare & Wellness Trust of (GRX) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$10.13 0.00% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $10.11

The Gabelli Healthcare & Wellness Trust of (GRX) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $173.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on GRX Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is GRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, The Gabelli Healthcare & Wellness Trust of (NYSE: GRX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $10.13 (0.00% 1D, market cap $173.2M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, GRX ranks #543 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does GRX compare to GNT and SCM in the Financials sector?

▼

Within the Financials sector (Finance/Investors Services), GRX carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, GNT (GAMCO Natural Resources Gold & Income Trust) holds a D grade (46/100 RQD, P/E N/A, ROIC —, cap $152.8M) and SCM (Stellus Capital Investment Corporation) posts a E grade (34/100 RQD, P/E 7.4x, ROIC 7.3%, cap $200.5M). Among the 5-stock peer group, SCM leads on earnings multiple (7.4x) while SCM leads on capital efficiency (7.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for GRX?

▼

For The Gabelli Healthcare & Wellness Trust of (GRX), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #543 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $10.11 (-0.19%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 0.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY • 51.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-0.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for GRX)Realized 20D OHLCV Swing Band: ±2.6%

Deterministic 5-Pillar Attribution (56/100 Composite)

🔍 WHY GRX SCORES 56/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+13/20 pts (23% of score)

20D Institutional Volume Accumulation (±2.6% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$9.61+4.2% Next Q

Q2 (-2Q)

Grade C-$10.01-0.1% Next Q

Q3 (-1Q)

Grade C-$10.00+1.3% Next Q

Current

Grade D+$10.13-0.4% Hist 90D α

Trajectory: D (48) → D+ (56)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the GRX Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 56/100 (D+) score, GRX faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($9.83) or 200D SMA ($9.52) invalidates the momentum regime and cuts Target Base ($10.04) toward Bear Floor ($7.83).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $GRX• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “GRX Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 56%NO 44%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • Trailing 12 Months

How GRX Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$4.8M (0.1% FCF Margin)

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GRX)

✓Walkthrough of GRX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

GRX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +12.06%📐 HORIZONTAL RANGE

2026-11-02O $10.01H $10.13L $10.01C $10.13VOL 16.6K

RES: $10.87SUP: $9.24SMA50: $9.83SMA200: $9.52

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

GRX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 GRX Butterfly Map → + Track GRX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on GRX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for GRX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for GRX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GRX)

Financials Rank #543 of 1096 ⚔️ GNT vs GRX Full Matrix →

1. Head-to-Head Financials Peer Comparison (GRX vs. GNT, SCM, FTF, ACV)

Industry: Finance/Investors Services (37 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, The Gabelli Healthcare & Wellness Trust of (GRX) ranks #543 by composite RQD confidence (56/100, grade D+) and #910 by equity capitalization ($173.2M). Within this direct 5-issuer industry benchmark cohort, SCM leads on earnings valuation at 7.4x trailing P/E, while SCM leads on capital efficiency and profitability with 7.3% ROIC and — gross margin. GRX currently leads its immediate peer cohort in composite quantitative strength at 56/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
GRX ACTIVE The Gabelli Healthcare & Wellness Trust of	D+	56/100	—	—	—	0.00%	$173.2M	Benchmark Subject
GNT GAMCO Natural Resources Gold & Income Trust	D	46/100	—	—	—	-1.93%	$152.8M	/gnt-vs-grx →
SCM Stellus Capital Investment Corporation	E	34/100	7.4x	—	7.3%	-0.57%	$200.5M	/scm-vs-grx →
FTF Franklin Limited Duration Income Trust of	D	44/100	—	—	—	-0.18%	$219.8M	/ftf-vs-grx →
ACV Virtus Diversified Income & Convertible Fund of	D-	42/100	—	—	—	-1.00%	$249.7M	/acv-vs-grx →

2. GRX Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

The Gabelli Healthcare & Wellness Trust of (GRX) operates in Finance/Investors Services (Financials) with an equity capitalization of $173.2M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. GRX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is GRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does GRX compare to GNT and SCM in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for GRX?

Where is GRX trading relative to its 50-day, 200-day, and 52-week technical levels?

GRX last traded at $10.13 (0.00% on volume of 22,529 shares), positioning the stock +3.05% above its 50-day simple moving average ($9.83) and +6.41% above its 200-day simple moving average ($9.52). Across its 52-week range of $8.80 to $10.23, GRX sits at the 93.0% percentile with a 14-day RSI of 66.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±2.6% ($9.87 to $10.39).

GRX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is The Gabelli Healthcare & Wellness Trust of (GRX)?

In Trailing 12 Months, GRX converted $4.0B of revenue into a 52% gross margin, 27% operating margin, and $4.8M in free cash flow (0.1% FCF margin).

Direct Sub-Reports: GRX RQD Cockpit GRX 12M Forecast GRX Earnings & Move GRX Dividends & DRIP GRX Insiders & 13F GRX Whale Options GRX Profit Sankey GRX News & Why